From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

MILFORD, Mass., Oct. 10, 2024 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify ...

RNA vaccine technology has emerged as a groundbreaking approach in the field of immunology and infectious disease prevention.

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.

A biotech that lost federal funding Tuesday following Health Secretary Robert F. Kennedy Jr.’s edict that his agency’s pandemic preparedness division stop funding development of messenger RNA-based ...

The FDA placed a clinical hold on BioNTech’s Phase 1/2a trial for its investigational RNA-based malaria vaccine, BNT165e. BioNTech paused the study and is working with the FDA to address its requests ...

An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

Companies are racing to create a safe, effective vaccine at record speed. The world's leading drug companies, universities and governments are racing to develop a vaccine for COVID-19, the disease ...

Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and other therapeutic areas, and ...

SAN FRANCISCO -- As more people are getting vaccinated, medical experts in the United Kingdom and the U.S are holding trials to find out if giving two doses of a different COVID vaccine improves your ...